Ranking Invest

AbCellera Biologics Inc.

Segmento: Healthcare AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Indicadores Básicos

Valor de Mercado

$ 1.28 Bi

IVR

0.67

IVR2

-0.13

Índices de Previsibilidade

Faturamento

3.13

Lucro

5.16

Margem

1.27

Índices de Tendência

Faturamento

-6.58

Lucro

-8.55

Margem

-10.20

Índices de Endividamento

DIV/PAT

-0.09

DIV/L4T

0.57

Dívida Líquida

-$ 96.06 Mi

Patrimônio Líquido

$ 1.02 Bi

L4T

-$ 167.87 Mi

MM4T

-761.10%

Dívidas
Dividendos
Cotação: $4.29

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre